Literature DB >> 8818358

Analysis of the effects of alpha 1-adrenoceptor antagonists on noradrenaline-mediated contraction of rat small mesenteric artery.

P H Van der Graaf1, N P Shankley, J W Black.   

Abstract

1. In this study, we examined the interaction between noradrenaline (NA) and phenylephrine (PE) with seven antagonists (prazosin, tamsulosin, phentolamine, WB-4101, 5-methylurapidil, spiperone and HV 723) in an attempt to characterize the alpha 1-adrenoceptor population of the rat isolated small mesenteric artery (SMA) preparation. 2. Six of the seven antagonists investigated produced concentration-dependent, parallel, rightward shift of the NA concentration-effect (E/[A]) curves. The exception was tamsulosin, which produced significant decrease of the upper asymptote. In the case of 5-methylurapidil and HV723, the Schild plot slope parameters were not significantly different from unity over the range of concentrations used. However, the Schild plot slopes obtained for the other antagonists were all significantly greater than unity, inconsistent with expectations for simple competitive antagonism. 3. HV723, prazosin and tamsulosin were also tested using PE as an agonist. All three antagonists produced concentration-dependent, parallel, rightward shifts of the PE curves and Schild analysis yielded slope parameters not significantly different from unity. The pKB estimates obtained for tamsulosin and prazosin were not significantly different from the pA2 values obtained when NA was used as agonist. In the case of HV723, the 95% confidence intervals for the pKB values yielded with NA and PE did not overlap (pKB = 8.80-9.13 and 8.15-8.77 for NA and PE, respectively). 4. In the absence of evidence to indicate that the steep Schild plots were due to failure to satisfy the basic criteria for quantitative analysis in a one-receptor system, we considered the possibility that the complexity was caused by an action of NA at inhibitory D1 receptors. The selective D1 receptor antagonists, SCH-23390 (10 nM), had no significant effect on the NA E/[A] control curve, but the apparent potency of 100 nM prazosin was reduced by approximately 3.5 fold. 5. This study indicates that the steep Schild plots obtained from the interaction between NA and alpha 1-adrenoceptor antagonists were due to the simultaneous activation of inhibitory D1 receptors by NA. Notwithstanding this complexity, our explanatory model of the system (see Appendix) suggests that the antagonist affinity values estimated in the absence of D1 receptor block were not significantly affected by this other action of NA. The low affinity estimate obtained for prazosin suggests that the pharmacologically-defined alpha IL-subtype operates in the SMA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8818358      PMCID: PMC1909598          DOI: 10.1111/j.1476-5381.1996.tb15538.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  38 in total

1.  Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats.

Authors:  M J Mulvany; W Halpern
Journal:  Circ Res       Date:  1977-07       Impact factor: 17.367

2.  Correlation of the directly observed responses of mesenteric vessles of the rat to nerve stimulation and noradrenaline with the distribution of adrenergic nerves.

Authors:  J B Furness; J M Marshall
Journal:  J Physiol       Date:  1974-05       Impact factor: 5.182

Review 3.  Novel dopamine receptors half a decade later.

Authors:  P Sokoloff; J C Schwartz
Journal:  Trends Pharmacol Sci       Date:  1995-08       Impact factor: 14.819

Review 4.  International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update.

Authors:  J P Hieble; D B Bylund; D E Clarke; D C Eikenburg; S Z Langer; R J Lefkowitz; K P Minneman; R R Ruffolo
Journal:  Pharmacol Rev       Date:  1995-06       Impact factor: 25.468

5.  Coupling of human D-1 dopamine receptors to different guanine nucleotide binding proteins. Evidence that D-1 dopamine receptors can couple to both Gs and G(o).

Authors:  K Kimura; B H White; A Sidhu
Journal:  J Biol Chem       Date:  1995-06-16       Impact factor: 5.157

6.  The model of functional interaction. I. Development and first check of a new model of functional synergism and antagonism.

Authors:  F G van den Brink
Journal:  Eur J Pharmacol       Date:  1973-06       Impact factor: 4.432

7.  A model of two functionally antagonistic receptor populations activated by the same agonist.

Authors:  E Szabadi
Journal:  J Theor Biol       Date:  1977-11-07       Impact factor: 2.691

8.  Exposure and characterization of the action of noradrenaline at dopamine receptors mediating endothelium-independent relaxation of rat isolated small mesenteric arteries.

Authors:  P H Van der Graaf; P R Saxena; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

9.  Functional evidence equating the pharmacologically-defined alpha 1A- and cloned alpha 1C-adrenoceptor: studies in the isolated perfused kidney of rat.

Authors:  D R Blue; D W Bonhaus; A P Ford; J R Pfister; N A Sharif; I A Shieh; R L Vimont; T J Williams; D E Clarke
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

10.  Characterization of alpha 1-adrenoceptors mediating vasoconstriction to noradrenaline and nerve stimulation in the isolated perfused mesentery of rat.

Authors:  T J Williams; D E Clarke
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

View more
  5 in total

1.  A comparison of effects measured with isotonic and isometric recording: II. Concentration-effect curves for physiological antagonists.

Authors:  R B Barlow; S M Bond; C Grant; D S McQueen; Z Yaqoob
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

2.  Quantitative systems pharmacology analysis of drug combination and scaling to humans: the interaction between noradrenaline and vasopressin in vasoconstriction.

Authors:  Anyue Yin; Akihiro Yamada; Wiro B Stam; Johan G C van Hasselt; Piet H van der Graaf
Journal:  Br J Pharmacol       Date:  2018-07-10       Impact factor: 8.739

Review 3.  Subtypes of functional alpha1-adrenoceptor.

Authors:  James R Docherty
Journal:  Cell Mol Life Sci       Date:  2009-10-28       Impact factor: 9.261

4.  Analysis of alpha 1L-adrenoceptor pharmacology in rat small mesenteric artery.

Authors:  W B Stam; P H Van der Graaf; P R Saxena
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

5.  Alpha1-adrenoceptor subtypes involved in vasoconstrictor responses to exogenous and neurally released noradrenaline in rat femoral resistance arteries.

Authors:  Joseph Zacharia; Chris Hillier; Allan MacDonald
Journal:  Br J Pharmacol       Date:  2004-02-23       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.